
    
      The study will consist of the following 4 treatment groups.:

        1. Standard dose Advagraf with angiotensin-converting enzyme inhibitor (ACEi)/angiotensin
           receptor blocker (ARB) antihypertensive therapy

        2. Standard dose Advagraf without ACEi/ARB antihypertensive therapy

        3. Low dose Advagraf with ACEi/ARB antihypertensive therapy

        4. Low dose Advagraf without ACEi/ARB antihypertensive therapy
    
  